Thomas D. Kummet, M.D., Ph.D.
Associate Professor, Clinical Medicine

Carl T. Hayden VA Medical Center
650 E. Indian School Rd.
Phoenix, AZ 85012
Phone: 602-277-5551

EDUCATION:

St. John's University, 1973 (BS)
University of Minnesota Medical School, 1978 (MD)
University of Minnesota, 1978 (MPH)

RESEARCH INTERESTS:

My research interests have focused on the development of new chemotherapy drugs for Lung, Colorectal and Prostate cancer, and on new schedules for administering those chemotherapy agents. In addition, I have studied the effects of a patient's other concurrent medical conditions on the outcome of cancer treatment.

SELECTED PUBLICATIONS:

Salvatore J, Harrington J, Kummet T. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: Initial safety and toxicity data. Bioelectromagnetics 24: 524-527, 2003.

Salvatore J, Cooper B, Shah I, Kummet T. Primary Pancreatic Lymphoma: Case report, literature review, and Nomenclature Proposal. Medical Oncology 17:237-247, 2000.

Kummet T, Meyskens F. Vitamin A: A potential inhibitor of human cancer. Seminars in Oncology 10: 281-289, 1983.

Kummet T, Doll D. Chemotherapy of pulmonary Blastoma: A case report and review of the literature. Med Ped Oncology 10: 27-33, 1982.

SPONSORED RESEARCH THROUGH MSRP:

Tara Kelley-Gregory (MSRP 2004): "Anemia in patients with prostate cancer treated with radiation versus androgen ablation therapy versus both radiation and androgen ablation therapies."

Last updated: 11/24/2004